(ISSN: 1746-0913, 1746-0921)
There are widespread efforts to elucidate new biologic pathways and gene products in microbiology with a view to developing potential therapeutic strategies to combat or prevent infection. At the same time, the development of resistance to current treatment strategies is a continuing problem. In this setting, Future Microbiology provides an interdisciplinary forum for all scientists with a keen interest in infectious diseases. The journal includes news and views, full review articles, clinical research, literature awareness, concise commentary and analysis, and reports from the conference circuit.
- Molecular basis of microbial diseases
- Microbe–host interactions
- Overviews highlighting optimal therapeutic and diagnostic approaches, along with potential future options
- Use of microbes in the treatment of disease and genetic engineering
- Summaries evaluating newly approved antimicrobial agents
- Pharmacoeconomics and cost–benefit issues in microbiology
- New and re-emerging microbes impacting human health
- Microbial genome research, and the implications to higher organisms
- Microbes and cancer
- Epidemiologic studies and trends
- The problem of drug resistance, and potential methods to overcome this
- Defense against the use of microbes in bioterrorism
Articles are subject to peer-review by three independent referees on a double-blind basis. Authors publishing in the journal are asked to disclose any professional or financial interest that may be perceived as causing a conflict of interest in the context of the article.
The journal welcomes unsolicited article proposals.